Bajaj Healthcare Ltd
BAJAJHCARE (NSE)

278.65

769.03
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for Bajaj Healthcare Ltd stands at 5 against 7, three months back.

Bajaj Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of bulk drugs and pharmaceutical products. The Company's segments include manufacturing of Bulk Drugs, and Formulation. The Company manufactures and markets Active Pharmaceutical Ingredients (APIs), Intermediates and Finished Dosage Formulations (FDFs) with focus on Vitamins, Amino Acids, Anti-Convulsants and other Finished Dosage Forms (FDFs) catering to various therapeutic segments. The Company's product portfolio consists of various APIs in the therapeutic categories of Neutraceutical (Amino Acids), Vitamins, Anti-Convulsants, Bactericidal and Bacteriostatic, Diuretic and Vasodilator, Mineral and Nutritional supplements, Bronchodilater/Anti-asthmatic and Nootropics. Its FDFs include various therapeutic segments, such as Antibiotics, Anti-Arrhythmia, Anti-Convulsants, Anti-Diabetes, Anti-Platelets, Vitamins and its Derivatives and Anti-Hypertensive.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
311.56
100 DMA ()
342.78
200 DMA ()
0.00
52 Weeks Range
257.45
496.30
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity